ATF3	B:C1307893
expression	O
in	O
cardiomyocytes	O
preserves	O
homeostasis	O
in	O
the	O
heart	O
and	O
controls	O
peripheral	O
glucose	O
tolerance	O
.	O

ATF3	O
expression	B:C1171362
in	O
cardiomyocytes	O
preserves	O
homeostasis	O
in	O
the	O
heart	O
and	O
controls	O
peripheral	O
glucose	O
tolerance	O
.	O

ATF3	O
expression	O
in	O
cardiomyocytes	B:C0225828
preserves	O
homeostasis	O
in	O
the	O
heart	O
and	O
controls	O
peripheral	O
glucose	O
tolerance	O
.	O

ATF3	O
expression	O
in	O
cardiomyocytes	O
preserves	O
homeostasis	B:C0019868
in	O
the	O
heart	O
and	O
controls	O
peripheral	O
glucose	O
tolerance	O
.	O

ATF3	O
expression	O
in	O
cardiomyocytes	O
preserves	O
homeostasis	O
in	O
the	O
heart	B:C0018787
and	O
controls	O
peripheral	O
glucose	O
tolerance	O
.	O

ATF3	O
expression	O
in	O
cardiomyocytes	O
preserves	O
homeostasis	O
in	O
the	O
heart	O
and	O
controls	O
peripheral	B:C0205100
glucose	O
tolerance	O
.	O

Obesity	B:C0028754
and	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
trigger	O
a	O
harmful	O
stress	O
-	O
induced	O
cardiac	O
remodeling	I:C3658220
process	I:C3658220
known	O
as	O
cardiomyopathy	O
.	O

Obesity	O
and	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
trigger	O
a	O
harmful	O
stress	O
-	O
induced	O
cardiac	O
remodeling	I:C3658220
process	I:C3658220
known	O
as	O
cardiomyopathy	O
.	O

Obesity	O
and	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
)	O
trigger	O
a	O
harmful	O
stress	O
-	O
induced	O
cardiac	O
remodeling	I:C3658220
process	I:C3658220
known	O
as	O
cardiomyopathy	O
.	O

Obesity	O
and	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
trigger	O
a	O
harmful	O
stress	B:C0449430
-	O
induced	O
cardiac	O
remodeling	I:C3658220
process	I:C3658220
known	O
as	O
cardiomyopathy	O
.	O

Obesity	O
and	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
trigger	O
a	O
harmful	O
stress	O
-	O
induced	O
cardiac	B:C3658220
remodeling	I:C3658220
process	I:C3658220
known	O
as	O
cardiomyopathy	O
.	O

Obesity	O
and	O
type	O
2	I:C0011860
diabetes	I:C0011860
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
)	O
trigger	O
a	O
harmful	O
stress	O
-	O
induced	O
cardiac	O
remodeling	I:C3658220
process	I:C3658220
known	O
as	O
cardiomyopathy	B:C0878544
.	O

These	O
diseases	B:C0012634
represent	O
a	O
serious	O
and	O
widespread	O
health	O
problem	O
in	O
the	O
Western	O
world	O
;	O
however	O
the	O
underlying	O
molecular	O
basis	O
is	O
not	O
clear	O
.	O

These	O
diseases	O
represent	O
a	O
serious	O
and	O
widespread	B:C0205391
health	O
problem	O
in	O
the	O
Western	O
world	O
;	O
however	O
the	O
underlying	O
molecular	O
basis	O
is	O
not	O
clear	O
.	O

ATF3	B:C1412616
is	O
an	O
'	O
immediate	O
early	I:C0206256
'	I:C0206256
gene	I:C0206256
whose	O
expression	O
is	O
highly	O
and	O
transiently	O
induced	O
in	O
response	O
to	O
multiple	O
stressors	O
such	O
as	O
metabolic	O
,	O
oxidative	O
,	O
endoplasmic	O
reticulum	I:C3178870
and	O
inflammation	O
,	O
stressors	O
that	O
are	O
involved	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
cardiomyopathy	O
.	O

ATF3	O
is	O
an	O
'	O
immediate	B:C0206256
early	I:C0206256
'	I:C0206256
gene	I:C0206256
whose	O
expression	O
is	O
highly	O
and	O
transiently	O
induced	O
in	O
response	O
to	O
multiple	O
stressors	O
such	O
as	O
metabolic	O
,	O
oxidative	O
,	O
endoplasmic	O
reticulum	I:C3178870
and	O
inflammation	O
,	O
stressors	O
that	O
are	O
involved	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
cardiomyopathy	O
.	O

ATF3	O
is	O
an	O
'	O
immediate	O
early	I:C0206256
'	I:C0206256
gene	I:C0206256
whose	O
expression	B:C0017262
is	O
highly	O
and	O
transiently	O
induced	O
in	O
response	O
to	O
multiple	O
stressors	O
such	O
as	O
metabolic	O
,	O
oxidative	O
,	O
endoplasmic	O
reticulum	I:C3178870
and	O
inflammation	O
,	O
stressors	O
that	O
are	O
involved	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
cardiomyopathy	O
.	O

ATF3	O
is	O
an	O
'	O
immediate	O
early	I:C0206256
'	I:C0206256
gene	I:C0206256
whose	O
expression	O
is	O
highly	O
and	O
transiently	O
induced	O
in	O
response	B:C0542478
to	O
multiple	O
stressors	O
such	O
as	O
metabolic	O
,	O
oxidative	O
,	O
endoplasmic	O
reticulum	I:C3178870
and	O
inflammation	O
,	O
stressors	O
that	O
are	O
involved	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
cardiomyopathy	O
.	O

ATF3	O
is	O
an	O
'	O
immediate	O
early	I:C0206256
'	I:C0206256
gene	I:C0206256
whose	O
expression	O
is	O
highly	O
and	O
transiently	O
induced	O
in	O
response	O
to	O
multiple	O
stressors	O
such	O
as	O
metabolic	O
,	O
oxidative	B:C0242606
,	O
endoplasmic	O
reticulum	I:C3178870
and	O
inflammation	O
,	O
stressors	O
that	O
are	O
involved	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
cardiomyopathy	O
.	O

ATF3	O
is	O
an	O
'	O
immediate	O
early	I:C0206256
'	I:C0206256
gene	I:C0206256
whose	O
expression	O
is	O
highly	O
and	O
transiently	O
induced	O
in	O
response	O
to	O
multiple	O
stressors	O
such	O
as	O
metabolic	O
,	O
oxidative	O
,	O
endoplasmic	B:C3178870
reticulum	I:C3178870
and	O
inflammation	O
,	O
stressors	O
that	O
are	O
involved	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
cardiomyopathy	O
.	O

ATF3	O
is	O
an	O
'	O
immediate	O
early	I:C0206256
'	I:C0206256
gene	I:C0206256
whose	O
expression	O
is	O
highly	O
and	O
transiently	O
induced	O
in	O
response	O
to	O
multiple	O
stressors	O
such	O
as	O
metabolic	O
,	O
oxidative	O
,	O
endoplasmic	O
reticulum	I:C3178870
and	O
inflammation	B:C0021368
,	O
stressors	O
that	O
are	O
involved	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
cardiomyopathy	O
.	O

ATF3	O
is	O
an	O
'	O
immediate	O
early	I:C0206256
'	I:C0206256
gene	I:C0206256
whose	O
expression	O
is	O
highly	O
and	O
transiently	O
induced	O
in	O
response	O
to	O
multiple	O
stressors	O
such	O
as	O
metabolic	O
,	O
oxidative	O
,	O
endoplasmic	O
reticulum	I:C3178870
and	O
inflammation	O
,	O
stressors	O
that	O
are	O
involved	O
in	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
cardiomyopathy	O
.	O

ATF3	O
is	O
an	O
'	O
immediate	O
early	I:C0206256
'	I:C0206256
gene	I:C0206256
whose	O
expression	O
is	O
highly	O
and	O
transiently	O
induced	O
in	O
response	O
to	O
multiple	O
stressors	O
such	O
as	O
metabolic	O
,	O
oxidative	O
,	O
endoplasmic	O
reticulum	I:C3178870
and	O
inflammation	O
,	O
stressors	O
that	O
are	O
involved	O
in	O
type	O
2	I:C0011860
diabetes	I:C0011860
cardiomyopathy	B:C0878544
.	O

The	O
role	O
of	O
ATF3	B:C1307893
in	O
diabetic	O
cardiomyopathy	I:C0853897
is	O
currently	O
unknown	O
.	O

The	O
role	O
of	O
ATF3	O
in	O
diabetic	B:C0853897
cardiomyopathy	I:C0853897
is	O
currently	O
unknown	O
.	O

Our	O
research	B:C0035168
has	O
aimed	O
to	O
study	O
the	O
effect	O
of	O
ATF3	O
expression	O
on	O
cardiomyocytes	O
,	O
heart	O
function	I:C0232164
and	O
glucose	O
homeostasis	I:C1326961
in	O
an	O
obesity	O
-	O
induced	O
type	O
2	I:C0011860
diabetes	I:C0011860
mouse	O
model	I:C2986594
.	O

Our	O
research	O
has	O
aimed	O
to	O
study	O
the	O
effect	O
of	O
ATF3	B:C1307893
expression	O
on	O
cardiomyocytes	O
,	O
heart	O
function	I:C0232164
and	O
glucose	O
homeostasis	I:C1326961
in	O
an	O
obesity	O
-	O
induced	O
type	O
2	I:C0011860
diabetes	I:C0011860
mouse	O
model	I:C2986594
.	O

Our	O
research	O
has	O
aimed	O
to	O
study	O
the	O
effect	O
of	O
ATF3	O
expression	B:C1171362
on	O
cardiomyocytes	O
,	O
heart	O
function	I:C0232164
and	O
glucose	O
homeostasis	I:C1326961
in	O
an	O
obesity	O
-	O
induced	O
type	O
2	I:C0011860
diabetes	I:C0011860
mouse	O
model	I:C2986594
.	O

Our	O
research	O
has	O
aimed	O
to	O
study	O
the	O
effect	O
of	O
ATF3	O
expression	O
on	O
cardiomyocytes	B:C0225828
,	O
heart	O
function	I:C0232164
and	O
glucose	O
homeostasis	I:C1326961
in	O
an	O
obesity	O
-	O
induced	O
type	O
2	I:C0011860
diabetes	I:C0011860
mouse	O
model	I:C2986594
.	O

Our	O
research	O
has	O
aimed	O
to	O
study	O
the	O
effect	O
of	O
ATF3	O
expression	O
on	O
cardiomyocytes	O
,	O
heart	B:C0232164
function	I:C0232164
and	O
glucose	O
homeostasis	I:C1326961
in	O
an	O
obesity	O
-	O
induced	O
type	O
2	I:C0011860
diabetes	I:C0011860
mouse	O
model	I:C2986594
.	O

Our	O
research	O
has	O
aimed	O
to	O
study	O
the	O
effect	O
of	O
ATF3	O
expression	O
on	O
cardiomyocytes	O
,	O
heart	O
function	I:C0232164
and	O
glucose	B:C1326961
homeostasis	I:C1326961
in	O
an	O
obesity	O
-	O
induced	O
type	O
2	I:C0011860
diabetes	I:C0011860
mouse	O
model	I:C2986594
.	O

Our	O
research	O
has	O
aimed	O
to	O
study	O
the	O
effect	O
of	O
ATF3	O
expression	O
on	O
cardiomyocytes	O
,	O
heart	O
function	I:C0232164
and	O
glucose	O
homeostasis	I:C1326961
in	O
an	O
obesity	B:C0028754
-	O
induced	O
type	O
2	I:C0011860
diabetes	I:C0011860
mouse	O
model	I:C2986594
.	O

Our	O
research	O
has	O
aimed	O
to	O
study	O
the	O
effect	O
of	O
ATF3	O
expression	O
on	O
cardiomyocytes	O
,	O
heart	O
function	I:C0232164
and	O
glucose	O
homeostasis	I:C1326961
in	O
an	O
obesity	O
-	O
induced	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
mouse	O
model	I:C2986594
.	O

Our	O
research	O
has	O
aimed	O
to	O
study	O
the	O
effect	O
of	O
ATF3	O
expression	O
on	O
cardiomyocytes	O
,	O
heart	O
function	I:C0232164
and	O
glucose	O
homeostasis	I:C1326961
in	O
an	O
obesity	O
-	O
induced	O
type	O
2	I:C0011860
diabetes	I:C0011860
mouse	B:C2986594
model	I:C2986594
.	O

We	O
used	O
wild	B:C0026809
type	I:C0026809
mice	I:C0026809
(	O
wild	O
type	I:C0026809
mice	I:C0026809
)	O
as	O
well	O
as	O
mutant	O
mice	I:C0025930
with	O
a	O
cardiac	O
-	O
specific	O
ATF3	O
deficiency	O
(	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
)	O
.	O

We	O
used	O
wild	O
type	I:C0026809
mice	I:C0026809
(	O
wild	B:C0026809
type	I:C0026809
mice	I:C0026809
)	O
as	O
well	O
as	O
mutant	O
mice	I:C0025930
with	O
a	O
cardiac	O
-	O
specific	O
ATF3	O
deficiency	O
(	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
)	O
.	O

We	O
used	O
wild	O
type	I:C0026809
mice	I:C0026809
(	O
wild	O
type	I:C0026809
mice	I:C0026809
)	O
as	O
well	O
as	O
mutant	B:C0025930
mice	I:C0025930
with	O
a	O
cardiac	O
-	O
specific	O
ATF3	O
deficiency	O
(	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
)	O
.	O

We	O
used	O
wild	O
type	I:C0026809
mice	I:C0026809
(	O
wild	O
type	I:C0026809
mice	I:C0026809
)	O
as	O
well	O
as	O
mutant	O
mice	I:C0025930
with	O
a	O
cardiac	B:C0018787
-	O
specific	O
ATF3	O
deficiency	O
(	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
)	O
.	O

We	O
used	O
wild	O
type	I:C0026809
mice	I:C0026809
(	O
wild	O
type	I:C0026809
mice	I:C0026809
)	O
as	O
well	O
as	O
mutant	O
mice	I:C0025930
with	O
a	O
cardiac	O
-	O
specific	O
ATF3	B:C1412616
deficiency	O
(	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
)	O
.	O

We	O
used	O
wild	O
type	I:C0026809
mice	I:C0026809
(	O
wild	O
type	I:C0026809
mice	I:C0026809
)	O
as	O
well	O
as	O
mutant	O
mice	I:C0025930
with	O
a	O
cardiac	O
-	O
specific	O
ATF3	O
deficiency	O
(	O
ATF3	B:C0206745
-	I:C0206745
cKO	I:C0206745
)	O
.	O

Mice	B:C0026809
were	O
fed	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
(	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
)	O
for	O
15	O
weeks	O
.	O

Mice	O
were	O
fed	O
a	O
high	B:C0453819
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
(	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
)	O
for	O
15	O
weeks	O
.	O

Mice	O
were	O
fed	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
(	O
high	B:C0453819
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
)	O
for	O
15	O
weeks	O
.	O

high	B:C0453819
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
induced	O
high	O
ATF3	O
expression	O
in	O
cardiomyocytes	O
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
induced	O
high	O
ATF3	B:C1307893
expression	O
in	O
cardiomyocytes	O
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
induced	O
high	O
ATF3	O
expression	B:C1171362
in	O
cardiomyocytes	O
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
induced	O
high	O
ATF3	O
expression	O
in	O
cardiomyocytes	B:C0225828
.	O

Mice	B:C0026809
were	O
examined	O
for	O
cardiac	O
remodeling	I:C3658220
processes	I:C3658220
and	O
the	O
diabetic	O
state	I:C0271650
was	O
assessed	O
.	O

Mice	O
were	O
examined	B:C0332128
for	O
cardiac	O
remodeling	I:C3658220
processes	I:C3658220
and	O
the	O
diabetic	O
state	I:C0271650
was	O
assessed	O
.	O

Mice	O
were	O
examined	O
for	O
cardiac	B:C3658220
remodeling	I:C3658220
processes	I:C3658220
and	O
the	O
diabetic	O
state	I:C0271650
was	O
assessed	O
.	O

Mice	O
were	O
examined	O
for	O
cardiac	O
remodeling	I:C3658220
processes	I:C3658220
and	O
the	O
diabetic	B:C0271650
state	I:C0271650
was	O
assessed	O
.	O

Mice	O
were	O
examined	O
for	O
cardiac	O
remodeling	I:C3658220
processes	I:C3658220
and	O
the	O
diabetic	O
state	I:C0271650
was	O
assessed	B:C0220825
.	O

high	B:C0453819
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
exhibited	O
severe	O
cardiac	O
fibrosis	I:C1397307
,	O
higher	O
levels	O
of	O
heart	O
hypertrophic	I:C1383860
markers	O
,	O
increased	O
inflammation	O
and	O
worse	O
cardiac	O
function	I:C0232164
,	O
as	O
compared	O
to	O
WT	O
mice	I:C0026809
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	B:C0206745
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
exhibited	O
severe	O
cardiac	O
fibrosis	I:C1397307
,	O
higher	O
levels	O
of	O
heart	O
hypertrophic	I:C1383860
markers	O
,	O
increased	O
inflammation	O
and	O
worse	O
cardiac	O
function	I:C0232164
,	O
as	O
compared	O
to	O
WT	O
mice	I:C0026809
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
exhibited	O
severe	O
cardiac	B:C1397307
fibrosis	I:C1397307
,	O
higher	O
levels	O
of	O
heart	O
hypertrophic	I:C1383860
markers	O
,	O
increased	O
inflammation	O
and	O
worse	O
cardiac	O
function	I:C0232164
,	O
as	O
compared	O
to	O
WT	O
mice	I:C0026809
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
exhibited	O
severe	O
cardiac	O
fibrosis	I:C1397307
,	O
higher	O
levels	O
of	O
heart	B:C1383860
hypertrophic	I:C1383860
markers	O
,	O
increased	O
inflammation	O
and	O
worse	O
cardiac	O
function	I:C0232164
,	O
as	O
compared	O
to	O
WT	O
mice	I:C0026809
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
exhibited	O
severe	O
cardiac	O
fibrosis	I:C1397307
,	O
higher	O
levels	O
of	O
heart	O
hypertrophic	I:C1383860
markers	B:C0005516
,	O
increased	O
inflammation	O
and	O
worse	O
cardiac	O
function	I:C0232164
,	O
as	O
compared	O
to	O
WT	O
mice	I:C0026809
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
exhibited	O
severe	O
cardiac	O
fibrosis	I:C1397307
,	O
higher	O
levels	O
of	O
heart	O
hypertrophic	I:C1383860
markers	O
,	O
increased	O
inflammation	B:C0021368
and	O
worse	O
cardiac	O
function	I:C0232164
,	O
as	O
compared	O
to	O
WT	O
mice	I:C0026809
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
exhibited	O
severe	O
cardiac	O
fibrosis	I:C1397307
,	O
higher	O
levels	O
of	O
heart	O
hypertrophic	I:C1383860
markers	O
,	O
increased	O
inflammation	O
and	O
worse	B:C1457868
cardiac	O
function	I:C0232164
,	O
as	O
compared	O
to	O
WT	O
mice	I:C0026809
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
exhibited	O
severe	O
cardiac	O
fibrosis	I:C1397307
,	O
higher	O
levels	O
of	O
heart	O
hypertrophic	I:C1383860
markers	O
,	O
increased	O
inflammation	O
and	O
worse	O
cardiac	B:C0232164
function	I:C0232164
,	O
as	O
compared	O
to	O
WT	O
mice	I:C0026809
.	O

high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
exhibited	O
severe	O
cardiac	O
fibrosis	I:C1397307
,	O
higher	O
levels	O
of	O
heart	O
hypertrophic	I:C1383860
markers	O
,	O
increased	O
inflammation	O
and	O
worse	O
cardiac	O
function	I:C0232164
,	O
as	O
compared	O
to	O
WT	B:C0026809
mice	I:C0026809
.	O

Interestingly	O
,	O
high	B:C0453819
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
display	O
increased	O
hyperglycemia	O
and	O
reduced	O
glucose	O
tolerance	O
,	O
despite	O
higher	O
blood	I:C0852795
insulin	I:C0852795
levels	I:C0852795
,	O
as	O
compared	O
to	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
WT	O
mice	I:C0026809
.	I:C0026809

Interestingly	O
,	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	B:C0206745
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
display	O
increased	O
hyperglycemia	O
and	O
reduced	O
glucose	O
tolerance	O
,	O
despite	O
higher	O
blood	I:C0852795
insulin	I:C0852795
levels	I:C0852795
,	O
as	O
compared	O
to	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
WT	O
mice	I:C0026809
.	I:C0026809

Interestingly	O
,	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
display	O
increased	O
hyperglycemia	B:C0020456
and	O
reduced	O
glucose	O
tolerance	O
,	O
despite	O
higher	O
blood	I:C0852795
insulin	I:C0852795
levels	I:C0852795
,	O
as	O
compared	O
to	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
WT	O
mice	I:C0026809
.	I:C0026809

Interestingly	O
,	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
display	O
increased	O
hyperglycemia	O
and	O
reduced	O
glucose	O
tolerance	O
,	O
despite	O
higher	B:C0852795
blood	I:C0852795
insulin	I:C0852795
levels	I:C0852795
,	O
as	O
compared	O
to	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
WT	O
mice	I:C0026809
.	I:C0026809

Interestingly	O
,	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
display	O
increased	O
hyperglycemia	O
and	O
reduced	O
glucose	O
tolerance	O
,	O
despite	O
higher	O
blood	I:C0852795
insulin	I:C0852795
levels	I:C0852795
,	O
as	O
compared	O
to	O
high	B:C0453819
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
WT	O
mice	I:C0026809
.	I:C0026809

Interestingly	O
,	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
ATF3	O
-	I:C0206745
cKO	I:C0206745
mice	I:C0206745
display	O
increased	O
hyperglycemia	O
and	O
reduced	O
glucose	O
tolerance	O
,	O
despite	O
higher	O
blood	I:C0852795
insulin	I:C0852795
levels	I:C0852795
,	O
as	O
compared	O
to	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
fed	O
WT	B:C0026809
mice	I:C0026809
.	I:C0026809

Elevated	O
levels	O
of	O
the	O
cardiac	B:C0018787
inflammatory	O
cytokines	I:C0079189
IL	O
-	I:C0021760
6	I:C0021760
and	O
TNFα	O
leading	O
to	O
impaired	O
insulin	O
signalling	I:C1155395
may	O
partially	O
explain	O
the	O
peripheral	O
glucose	O
intolerance	O
.	O

Elevated	O
levels	O
of	O
the	O
cardiac	O
inflammatory	B:C0079189
cytokines	I:C0079189
IL	O
-	I:C0021760
6	I:C0021760
and	O
TNFα	O
leading	O
to	O
impaired	O
insulin	O
signalling	I:C1155395
may	O
partially	O
explain	O
the	O
peripheral	O
glucose	O
intolerance	O
.	O

Elevated	O
levels	O
of	O
the	O
cardiac	O
inflammatory	O
cytokines	I:C0079189
IL	B:C0021760
-	I:C0021760
6	I:C0021760
and	O
TNFα	O
leading	O
to	O
impaired	O
insulin	O
signalling	I:C1155395
may	O
partially	O
explain	O
the	O
peripheral	O
glucose	O
intolerance	O
.	O

Elevated	O
levels	O
of	O
the	O
cardiac	O
inflammatory	O
cytokines	I:C0079189
IL	O
-	I:C0021760
6	I:C0021760
and	O
TNFα	B:C1456820
leading	O
to	O
impaired	O
insulin	O
signalling	I:C1155395
may	O
partially	O
explain	O
the	O
peripheral	O
glucose	O
intolerance	O
.	O

Elevated	O
levels	O
of	O
the	O
cardiac	O
inflammatory	O
cytokines	I:C0079189
IL	O
-	I:C0021760
6	I:C0021760
and	O
TNFα	O
leading	O
to	O
impaired	O
insulin	B:C1155395
signalling	I:C1155395
may	O
partially	O
explain	O
the	O
peripheral	O
glucose	O
intolerance	O
.	O

Elevated	O
levels	O
of	O
the	O
cardiac	O
inflammatory	O
cytokines	I:C0079189
IL	O
-	I:C0021760
6	I:C0021760
and	O
TNFα	O
leading	O
to	O
impaired	O
insulin	O
signalling	I:C1155395
may	O
partially	O
explain	O
the	O
peripheral	B:C0205100
glucose	O
intolerance	O
.	O

Cardiac	B:C0018787
ATF3	O
has	O
a	O
protective	O
role	O
in	O
dampening	O
the	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
cardiac	O
remodeling	I:C3658220
processes	I:C3658220
.	O

Cardiac	O
ATF3	B:C1307893
has	O
a	O
protective	O
role	O
in	O
dampening	O
the	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
cardiac	O
remodeling	I:C3658220
processes	I:C3658220
.	O

Cardiac	O
ATF3	O
has	O
a	O
protective	O
role	O
in	O
dampening	O
the	O
high	B:C0453819
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
cardiac	O
remodeling	I:C3658220
processes	I:C3658220
.	O

Cardiac	O
ATF3	O
has	O
a	O
protective	O
role	O
in	O
dampening	O
the	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
cardiac	B:C3658220
remodeling	I:C3658220
processes	I:C3658220
.	O

ATF3	B:C1307893
exerts	O
both	O
local	O
and	O
systemic	O
effects	O
related	O
to	O
type	O
2	I:C0011860
diabetes	I:C0011860
-	O
induced	O
cardiomyopathy	O
.	O

ATF3	O
exerts	B:C0015264
both	O
local	O
and	O
systemic	O
effects	O
related	O
to	O
type	O
2	I:C0011860
diabetes	I:C0011860
-	O
induced	O
cardiomyopathy	O
.	O

ATF3	O
exerts	O
both	O
local	O
and	O
systemic	O
effects	O
related	O
to	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
-	O
induced	O
cardiomyopathy	O
.	O

ATF3	O
exerts	O
both	O
local	O
and	O
systemic	O
effects	O
related	O
to	O
type	O
2	I:C0011860
diabetes	I:C0011860
-	O
induced	O
cardiomyopathy	B:C0878544
.	O

This	O
study	O
provides	O
a	O
strong	O
relationship	O
between	O
heart	B:C3658220
remodeling	I:C3658220
processes	I:C3658220
and	O
blood	O
glucose	O
homeostasis	I:C1326961
.	I:C1326961

This	O
study	O
provides	O
a	O
strong	O
relationship	O
between	O
heart	O
remodeling	I:C3658220
processes	I:C3658220
and	O
blood	B:C0005767
glucose	O
homeostasis	I:C1326961
.	I:C1326961

This	O
study	O
provides	O
a	O
strong	O
relationship	O
between	O
heart	O
remodeling	I:C3658220
processes	I:C3658220
and	O
blood	O
glucose	B:C1326961
homeostasis	I:C1326961
.	I:C1326961

